Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-096273
Filing Date
2025-07-16
Accepted
2025-07-16 16:17:54
Documents
1
Period of Report
2025-07-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3935
  Complete submission text file 0000950170-25-096273.txt   5344
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39593 | Film No.: 251127648

Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Issuer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)